UTAH MEDICAL PRODUCTS, INC. Shareholders' Equity
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Shareholders' Equity of $122.03 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $122.03M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $120.37M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $119.27M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $118.25M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $122.03M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $120.37M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $119.27M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $118.25M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $117.53M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $117.05M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $117.43M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $124.20M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $124.05M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $127.74M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $128.31M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $123.70M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $121.76M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $118.02M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $114.25M 10-Q · filed 2024-05-10 | |
| 2022-09-30 | $108.19M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $107.47M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $109.17M 10-Q · filed 2023-05-05 | |
| 2021-12-31 | $107.14M 10-Q · filed 2023-05-05 | |
| 2021-09-30 | $109.98M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $107.36M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $104.88M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $102.82M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $98.42M 10-Q/A · filed 2020-11-09 | |
| 2020-06-30 | $95.29M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $94.39M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $101.09M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $94.99M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $93.91M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $92.17M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $88.99M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $88.83M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $83.36M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $82.69M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $78.12M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $81.20M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $77.25M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $72.54M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $69.24M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $72.67M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $71.07M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $71.66M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $69.65M 10-K · filed 2018-03-06 | |
| 2015-09-30 | $68.35M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $68.19M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $63.84M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $64.56M 10-K · filed 2018-03-06 | |
| 2014-09-30 | $64.22M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $64.97M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $62.94M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $60.58M 10-K · filed 2017-03-08 | |
| 2013-09-30 | $57.08M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $52.64M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $50.72M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $50.97M 10-K · filed 2016-03-10 | |
| 2012-09-30 | $48.71M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $45.55M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $44.53M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $40.76M 10-K · filed 2015-03-12 | $40.76M 10-K · filed 2012-03-12 |
| 2011-09-30 | $40.37M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $40.00M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $37.79M 10-K · filed 2014-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |